Clinical trial
Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT06348524 is registered in ClinicalTrials.gov with Transmed Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ferumoxytol-enhanced Magnetic Resonance Imaging
- Lead sponsor
- Transmed Solutions
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 1, 2015
- Completion date
- December 30, 2022
- Enrollment
- 36 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.